{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T08:43:05Z","timestamp":1775119385587,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T00:00:00Z","timestamp":1596844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T00:00:00Z","timestamp":1596844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["103-2313-B-002-040-MY2"],"award-info":[{"award-number":["103-2313-B-002-040-MY2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["TMU108-AE1-B03"],"award-info":[{"award-number":["TMU108-AE1-B03"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Osteoporosis is a metabolic bone disorder characterized by deterioration in the quantity and quality of bone tissue, with a consequent increase susceptibility to fracture.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we sought to determine the efficacy of platelet-rich fibrin releasates (PRFr) in augmenting the therapeutic effects of stem cell-based therapy in treating osteoporotic bone disorder. An osteoporosis mouse model was established through bilateral ovariectomy on 12-week-old female ICR (Institute of Cancer Research) mice. Eight weeks postoperatively, the ovariectomized (OVX) mice were left untreated (control) or injected with PRFr, bone marrow stem cells (BMSCs), or the combination of BMSCs and PRFr. Two different injection (single versus quadruple) dosages were tested to investigate the accumulative effects of BMSCS and PRFr on bone quality.<\/jats:p>\n                    <jats:p>Eight weeks after injection, the changes in tibial microstructural profiles included the percentage of bone volume versus total tissue volume (BV\/TV, %), bone mineral density (BMD, g\/cm3), trabecular number (Tb.N, number\/mm), and trabecular separation (Tb.Sp, mm) and bony histology were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Postmenopausal osteoporosis model was successfully established in OVX mice, evidenced by reduced BMD, decreased BV\/TV, lower Tb.N but increased Tb.Sp. Eight weeks after injection, there was no significant change to BMD and bone trabeculae could be detected in mice that received single-injection regimen. In contrast, in mice which received 4 doses of combined PRFr and BMSCs, the BMD, BV\/TV, and TB.N increased, and the TB.Sp decreased significantly compared to untreated OVX mice. Moreover, the histological analysis showed the trabecular spacing become narrower in OVX-mice treated with quadruple injection of BMSCs and combined PRFr and BMSCs than untreated control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The systemic administration of combined BMSCs and PRFr protected against OVX-induced bone mass loss in mice. Moreover, the improvement of bony profile scores in quadruple-injection group is better than the single-injection group, probably through the increase in effect size of cells and growth factors. Our data also revealed the combination therapy of BMSCs and PRFr has better effect in enhancing osteogenesis, which may provide insight for the development of a novel therapeutic strategy in osteoporosis treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12891-020-03549-y","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T11:03:57Z","timestamp":1596884637000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Novel transplant of combined platelet-rich fibrin Releasate and bone marrow stem cells prevent bone loss in Ovariectomized osteoporotic mice"],"prefix":"10.1186","volume":"21","author":[{"given":"Chin-Chean","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeng-Hao","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Yuan","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hwa","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzong-Fu","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,8]]},"reference":[{"issue":"2","key":"3549_CR1","first-page":"92","volume":"43","author":"KN Tu","year":"2018","unstructured":"Tu KN, Lie JD, Wan CKV, Cameron M, Austel AG, Nguyen JK, Van K, Hyun D. Osteoporosis: a review of treatment options. P t. 2018;43(2):92\u2013104.","journal-title":"P t"},{"issue":"2","key":"3549_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cger.2014.01.009","volume":"30","author":"JE Sale","year":"2014","unstructured":"Sale JE, Beaton D, Bogoch E. Secondary prevention after an osteoporosis-related fracture: an overview. Clin Geriatr Med. 2014;30(2):317\u201332.","journal-title":"Clin Geriatr Med"},{"issue":"12","key":"3549_CR3","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1172\/JCI27071","volume":"115","author":"LG Raisz","year":"2005","unstructured":"Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest. 2005;115(12):3318\u201325.","journal-title":"J Clin Invest"},{"issue":"4","key":"3549_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S1534-5807(02)00157-0","volume":"2","author":"G Karsenty","year":"2002","unstructured":"Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dev Cell. 2002;2(4):389\u2013406.","journal-title":"Dev Cell"},{"issue":"5484","key":"3549_CR5","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","volume":"289","author":"GA Rodan","year":"2000","unstructured":"Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science. 2000;289(5484):1508\u201314.","journal-title":"Science"},{"issue":"1","key":"3549_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00774-007-0793-5","volume":"26","author":"E Seeman","year":"2008","unstructured":"Seeman E. Bone quality: the material and structural basis of bone strength. J Bone Miner Metab. 2008;26(1):1\u20138.","journal-title":"J Bone Miner Metab"},{"issue":"21","key":"3549_CR7","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1056\/NEJMra053077","volume":"354","author":"E Seeman","year":"2006","unstructured":"Seeman E, Delmas PD. Bone quality--the material and structural basis of bone strength and fragility. N Engl J Med. 2006;354(21):2250\u201361.","journal-title":"N Engl J Med"},{"issue":"3","key":"3549_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.maturitas.2014.04.016","volume":"78","author":"BL Clarke","year":"2014","unstructured":"Clarke BL. Anti-sclerostin antibodies: utility in treatment of osteoporosis. Maturitas. 2014;78(3):199\u2013204.","journal-title":"Maturitas"},{"issue":"2","key":"3549_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/14712598.2017.1280455","volume":"17","author":"L Bandeira","year":"2017","unstructured":"Bandeira L, Lewiecki EM, Bilezikian JP. Romosozumab for the treatment of osteoporosis. Expert Opin Biol Ther. 2017;17(2):255\u201363.","journal-title":"Expert Opin Biol Ther"},{"issue":"10","key":"3549_CR10","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1093\/rheumatology\/keu286","volume":"53","author":"M Kharazmi","year":"2014","unstructured":"Kharazmi M, Hallberg P, Warfvinge G, Michaelsson K. Risk of atypical femoral fractures and osteonecrosis of the jaw associated with alendronate use compared with other oral bisphosphonates. Rheumatology (Oxford). 2014;53(10):1911\u20133.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"3549_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.amjmed.2012.06.023","volume":"126","author":"M McClung","year":"2013","unstructured":"McClung M, Harris ST, Miller PD, Bauer DC, Davison KS, Dian L, Hanley DA, Kendler DL, Yuen CK, Lewiecki EM. Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday. Am J Med. 2013;126(1):13\u201320.","journal-title":"Am J Med"},{"issue":"12","key":"3549_CR12","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3928\/01477447-20091020-16","volume":"32","author":"SM Wirth","year":"2009","unstructured":"Wirth SM, Lawson AP, Sutphin SD, Adams VR. Osteonecrosis of the jaw associated with bisphosphonate therapy. Orthopedics. 2009;32(12):900.","journal-title":"Orthopedics"},{"issue":"5","key":"3549_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.stem.2010.10.004","volume":"7","author":"SL Teitelbaum","year":"2010","unstructured":"Teitelbaum SL. Stem cells and osteoporosis therapy. Cell Stem Cell. 2010;7(5):553\u20134.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"3549_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11914-013-0184-x","volume":"12","author":"B Antebi","year":"2014","unstructured":"Antebi B, Pelled G, Gazit D. Stem cell therapy for osteoporosis. Curr Osteoporos Rep. 2014;12(1):41\u20137.","journal-title":"Curr Osteoporos Rep"},{"issue":"28","key":"3549_CR15","doi-asserted-by":"publisher","first-page":"6773","DOI":"10.1016\/j.biomaterials.2011.05.080","volume":"32","author":"HY Liu","year":"2011","unstructured":"Liu HY, Wu AT, Tsai CY, Chou KR, Zeng R, Wang MF, Chang WC, Hwang SM, Su CH, Deng WP. The balance between adipogenesis and osteogenesis in bone regeneration by platelet-rich plasma for age-related osteoporosis. Biomaterials. 2011;32(28):6773\u201380.","journal-title":"Biomaterials"},{"issue":"7","key":"3549_CR16","doi-asserted-by":"publisher","first-page":"e1001019","DOI":"10.1371\/journal.pgen.1001019","volume":"6","author":"Y Tokuzawa","year":"2010","unstructured":"Tokuzawa Y, Yagi K, Yamashita Y, Nakachi Y, Nikaido I, Bono H, Ninomiya Y, Kanesaki-Yatsuka Y, Akita M, Motegi H, et al. Id4, a new candidate gene for senile osteoporosis, acts as a molecular switch promoting osteoblast differentiation. PLoS Genet. 2010;6(7):e1001019.","journal-title":"PLoS Genet"},{"key":"3549_CR17","doi-asserted-by":"publisher","first-page":"226","DOI":"10.12659\/MSM.897044","volume":"22","author":"C Wang","year":"2016","unstructured":"Wang C, Meng H, Wang X, Zhao C, Peng J, Wang Y. Differentiation of bone marrow Mesenchymal stem cells in osteoblasts and adipocytes and its role in treatment of osteoporosis. Med Sci Monit. 2016;22:226\u201333.","journal-title":"Med Sci Monit"},{"issue":"5","key":"3549_CR18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S8756-3282(00)00252-0","volume":"26","author":"AC Maurin","year":"2000","unstructured":"Maurin AC, Chavassieux PM, Frappart L, Delmas PD, Serre CM, Meunier PJ. Influence of mature adipocytes on osteoblast proliferation in human primary cocultures. Bone. 2000;26(5):485\u20139.","journal-title":"Bone"},{"issue":"12","key":"3549_CR19","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/nm1672","volume":"13","author":"Y Wan","year":"2007","unstructured":"Wan Y, Chong LW, Evans RM. PPAR-gamma regulates osteoclastogenesis in mice. Nat Med. 2007;13(12):1496\u2013503.","journal-title":"Nat Med"},{"issue":"10","key":"3549_CR20","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1902\/jop.2007.070116","volume":"78","author":"J Uggeri","year":"2007","unstructured":"Uggeri J, Belletti S, Guizzardi S, Poli T, Cantarelli S, Scandroglio R, Gatti R. Dose-dependent effects of platelet gel releasate on activities of human osteoblasts. J Periodontol. 2007;78(10):1985\u201391.","journal-title":"J Periodontol"},{"issue":"9","key":"3549_CR21","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/BOT.0b013e318188dbb7","volume":"22","author":"P Parsons","year":"2008","unstructured":"Parsons P, Butcher A, Hesselden K, Ellis K, Maughan J, Milner R, Scott M, Alley C, Watson JT, Horner A. Platelet-rich concentrate supports human mesenchymal stem cell proliferation, bone morphogenetic protein-2 messenger RNA expression, alkaline phosphatase activity, and bone formation in vitro: a mode of action to enhance bone repair. J Orthop Trauma. 2008;22(9):595\u2013604.","journal-title":"J Orthop Trauma"},{"issue":"34","key":"3549_CR22","doi-asserted-by":"publisher","first-page":"8802","DOI":"10.1016\/j.biomaterials.2012.08.054","volume":"33","author":"Y Man","year":"2012","unstructured":"Man Y, Wang P, Guo Y, Xiang L, Yang Y, Qu Y, Gong P, Deng L. Angiogenic and osteogenic potential of platelet-rich plasma and adipose-derived stem cell laden alginate microspheres. Biomaterials. 2012;33(34):8802\u201311.","journal-title":"Biomaterials"},{"issue":"3","key":"3549_CR23","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1016\/j.tripleo.2005.07.011","volume":"101","author":"J Choukroun","year":"2006","unstructured":"Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, Dohan AJ, Mouhyi J, Dohan DM. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(3):e56\u201360.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"3","key":"3549_CR24","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1016\/j.tripleo.2005.07.008","volume":"101","author":"DM Dohan","year":"2006","unstructured":"Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(3):e37\u201344.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"5","key":"3549_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.biologicals.2012.07.004","volume":"40","author":"M Kobayashi","year":"2012","unstructured":"Kobayashi M, Kawase T, Horimizu M, Okuda K, Wolff LF, Yoshie H. A proposed protocol for the standardized preparation of PRF membranes for clinical use. Biologicals. 2012;40(5):323\u20139.","journal-title":"Biologicals"},{"issue":"4","key":"3549_CR26","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s10517-014-2396-1","volume":"156","author":"SM Kosmacheva","year":"2014","unstructured":"Kosmacheva SM, Danilkovich NN, Shchepen AV, Ignatenko SI, Potapnev MP. Effect of platelet releasate on osteogenic differentiation of human mesenchymal bone marrow stem cells. Bull Exp Biol Med. 2014;156(4):560\u20135.","journal-title":"Bull Exp Biol Med"},{"key":"3549_CR27","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","volume":"152","author":"S Dutta","year":"2016","unstructured":"Dutta S, Sengupta P. Men and mice: relating their ages. Life Sci. 2016;152:244\u20138.","journal-title":"Life Sci"},{"issue":"9","key":"3549_CR28","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1590\/s0102-865020170090000009","volume":"32","author":"MAC Rocha","year":"2017","unstructured":"Rocha MAC, Silva LMC, Oliveira WA, Bezerra DO, Silva GCD, Silva LDS, Medeiros B, Baeta SAF, Carvalho MAM, Argolo NMN. Allogeneic mesenchymal stem cells and xenogenic platelet rich plasma, associated or not, in the repair of bone failures in rabbits with secondary osteoporosis. Acta Cir Bras. 2017;32(9):767\u201380.","journal-title":"Acta Cir Bras"},{"issue":"1","key":"3549_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.tripleo.2009.02.004","volume":"108","author":"CY Su","year":"2009","unstructured":"Su CY, Kuo YP, Tseng YH, Su CH, Burnouf T. In vitro release of growth factors from platelet-rich fibrin (PRF): a proposal to optimize the clinical applications of PRF. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108(1):56\u201361.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"10169","key":"3549_CR30","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","volume":"393","author":"JE Compston","year":"2019","unstructured":"Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet. 2019;393(10169):364\u201376.","journal-title":"Lancet"},{"issue":"1","key":"3549_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0736-0266(00)00010-3","volume":"19","author":"GF Muschler","year":"2001","unstructured":"Muschler GF, Nitto H, Boehm CA, Easley KA. Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res. 2001;19(1):117\u201325.","journal-title":"J Orthop Res"},{"issue":"1","key":"3549_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.arr.2005.10.001","volume":"5","author":"S Sethe","year":"2006","unstructured":"Sethe S, Scutt A, Stolzing A. Aging of mesenchymal stem cells. Ageing Res Rev. 2006;5(1):91\u2013116.","journal-title":"Ageing Res Rev"},{"issue":"13","key":"3549_CR33","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1177\/0363546517719876","volume":"45","author":"CC Wong","year":"2017","unstructured":"Wong CC, Chen CH, Chan WP, Chiu LH, Ho WP, Hsieh FJ, Chen YT, Yang TL. Single-stage cartilage repair using platelet-rich fibrin scaffolds with autologous cartilaginous grafts. Am J Sports Med. 2017;45(13):3128\u201342.","journal-title":"Am J Sports Med"},{"issue":"8","key":"3549_CR34","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.3390\/ijms18081722","volume":"18","author":"CC Wong","year":"2017","unstructured":"Wong CC, Kuo TF, Yang TL, Tsuang YH, Lin MF, Chang CH, Lin YH, Chan WP. Platelet-Rich Fibrin Facilitates Rabbit Meniscal Repair by Promoting Meniscocytes Proliferation, Migration, and Extracellular Matrix Synthesis. Int J Mol Sci. 2017;18(8):1722.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3549_CR35","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3390\/ijms21020577","volume":"21","author":"CC Wong","year":"2020","unstructured":"Wong CC, Ou KL, Lin YH, Lin MF, Yang TL, Chen CH, Chan WP. Platelet-Rich Fibrin Facilitates One-Stage Cartilage Repair by Promoting Chondrocytes Viability, Migration, and Matrix Synthesis. Int J Mol Sci. 2020;21(2):577.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3549_CR36","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2174\/187152810793938044","volume":"9","author":"PS Sharif","year":"2010","unstructured":"Sharif PS, Abdollahi M. The role of platelets in bone remodeling. Inflamm Allergy Drug Targets. 2010;9(5):393\u20139.","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"4","key":"3549_CR37","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3109\/03008207.2014.930140","volume":"55","author":"J Zou","year":"2014","unstructured":"Zou J, Yuan C, Wu C, Cao C, Yang H. The effects of platelet-rich plasma on the osteogenic induction of bone marrow mesenchymal stem cells. Connect Tissue Res. 2014;55(4):304\u20139.","journal-title":"Connect Tissue Res"},{"issue":"11","key":"3549_CR38","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1177\/0363546509349921","volume":"37","author":"TE Foster","year":"2009","unstructured":"Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37(11):2259\u201372.","journal-title":"Am J Sports Med"},{"issue":"1","key":"3549_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/ten.tec.2015.0223","volume":"22","author":"JM Jalowiec","year":"2016","unstructured":"Jalowiec JM, D'Este M, Bara JJ, Denom J, Menzel U, Alini M, Verrier S, Herrmann M. An in vitro investigation of platelet-rich plasma-gel as a cell and growth factor delivery vehicle for tissue engineering. Tissue Eng Part C Methods. 2016;22(1):49\u201358.","journal-title":"Tissue Eng Part C Methods"},{"issue":"3\u20134","key":"3549_CR40","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1089\/ten.tea.2010.0327","volume":"17","author":"YH Kang","year":"2011","unstructured":"Kang YH, Jeon SH, Park JY, Chung JH, Choung YH, Choung HW, Kim ES, Choung PH. Platelet-rich fibrin is a bioscaffold and reservoir of growth factors for tissue regeneration. Tissue Eng A. 2011;17(3\u20134):349\u201359.","journal-title":"Tissue Eng A"},{"key":"3549_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5402\/2013\/627367","volume":"2013","author":"SV Khiste","year":"2013","unstructured":"Khiste SV, Naik Tari R. Platelet-rich fibrin as a biofuel for tissue regeneration. ISRN Biomaterials. 2013;2013:1\u20136.","journal-title":"ISRN Biomaterials"},{"issue":"5","key":"3549_CR42","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.arthro.2018.11.014","volume":"35","author":"M Zhang","year":"2019","unstructured":"Zhang M, Zhen J, Zhang X, Yang Z, Zhang L, Hao D, Ren B. Effect of autologous platelet-rich plasma and gelatin sponge for tendon-to-bone healing after rabbit anterior cruciate ligament reconstruction. Arthroscopy. 2019;35(5):1486\u201397.","journal-title":"Arthroscopy"},{"issue":"3","key":"3549_CR43","first-page":"212","volume":"31","author":"HS Cho","year":"2011","unstructured":"Cho HS, Song IH, Park SY, Sung MC, Ahn MW, Song KE. Individual variation in growth factor concentrations in platelet-rich plasma and its influence on human mesenchymal stem cells. Korean J Lab Med. 2011;31(3):212\u20138.","journal-title":"Korean J Lab Med"},{"key":"3549_CR44","doi-asserted-by":"publisher","first-page":"9458396","DOI":"10.1155\/2016\/9458396","volume":"2016","author":"B Wei","year":"2016","unstructured":"Wei B, Huang C, Zhao M, Li P, Gao X, Kong J, Niu Y, Huang R, Quan J, Wei J, et al. Effect of Mesenchymal stem cells and platelet-rich plasma on the bone healing of Ovariectomized rats. Stem Cells Int. 2016;2016:9458396.","journal-title":"Stem Cells Int"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-020-03549-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-020-03549-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-020-03549-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T10:19:44Z","timestamp":1723371584000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-020-03549-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,8]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3549"],"URL":"https:\/\/doi.org\/10.1186\/s12891-020-03549-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-27529\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-27529\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-27529\/v3","asserted-by":"object"}]},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,8]]},"assertion":[{"value":"8 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures of bone marrow stem cells isolation and surgery on experimental animals were carried out according to the guide for the Care and Use of Laboratory Animals and was approved by the Institutional Animal Care and Use Committee (IACUC approval: NTU-102-EL-82 and NTU-102-EL-91).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflict of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"527"}}